Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.18 - $11.25 $13 - $855
-76 Reduced 5.17%
1,393 $0
Q2 2022

Aug 15, 2022

SELL
$0.28 - $0.67 $554 - $1,327
-1,982 Reduced 57.43%
1,469 $0
Q1 2022

May 12, 2022

SELL
$0.54 - $1.11 $828 - $1,702
-1,534 Reduced 30.77%
3,451 $2,000
Q4 2021

Feb 14, 2022

BUY
$1.01 - $2.03 $802 - $1,613
795 Added 18.97%
4,985 $5,000
Q3 2021

Nov 15, 2021

BUY
$1.97 - $2.67 $8,254 - $11,187
4,190 New
4,190 $8,000
Q2 2021

Aug 16, 2021

SELL
$2.15 - $2.99 $2,027 - $2,819
-943 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$2.19 - $3.98 $2,065 - $3,753
943 New
943 $3,000

About ThermoGenesis Holdings, Inc.


  • Ticker THMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,321,400
  • Description
  • ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...
More about THMO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.